3-amino-2-isopropyl-4(3H)-quinazolinone - Names and Identifiers
3-amino-2-isopropyl-4(3H)-quinazolinone - Physico-chemical Properties
Molecular Formula | C11H13N3O
|
Molar Mass | 203.24 |
Melting Point | 104-106°C(lit.) |
3-amino-2-isopropyl-4(3H)-quinazolinone - Risk and Safety
Hazard Symbols | Xi - Irritant
|
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin.
|
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36 - Wear suitable protective clothing.
|
WGK Germany | 3 |
3-amino-2-isopropyl-4(3H)-quinazolinone - Introduction
3-amino-2-isopropyl-4(3H)-quinazolinone is an organic compound with the chemical formula C12H15N3O.
Nature:
-Appearance: 3-amino-2-isopropyl-4(3H)-quinazolinone is a white crystalline solid.
-Solubility: It can be dissolved in organic solvents, such as ethanol and dimethyl sulfoxide, but it is almost insoluble in water.
Use:
-Drug: 3-amino-2-isopropyl-4(3H)-quinazolinone is an important intermediate compound used in the synthesis of other drugs in the pharmaceutical field, such as anti-cancer drugs, antibacterial drugs and anti-inflammatory drugs Wait.
-Chemical research: It can also be used as a catalyst and reagent for organic synthesis reactions.
Preparation Method:
-Synthesis route: 3-amino-2-isopropyl-4(3H)-quinazolinone can be synthesized by the reaction of carbamoyl chloride and N-isopropylbenzenone. The specific synthesis route is more complex and needs to be carried out in the synthesis laboratory.
Safety Information:
-Safety assessment: Due to the involvement of organic synthesis and possible drug synthesis, the safety assessment of 3-amino-2-isopropyl-4(3H)-quinazolinone depends on the specific use and synthesis process. Generally speaking, it is necessary to pay attention to reasonable operation, avoid contact with skin, eyes and inhalation, and follow laboratory safety procedures and related safety measures.
-Toxicity: Due to limited data, the toxicity of this substance requires further research and evaluation.
Last Update:2024-04-09 21:04:16